Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

Many nonhuman primate cells are unable to support the replication of HIV-1, whereas others are nonpermissive for infection by simian immunodeficiency virus from macaques (SIVmac). Here, we show that restricted HIV-1 and SIVmac infection of primate cell lines shares some salient features with Fv1 and...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Proceedings of the National Academy of Sciences - PNAS Ročník 99; číslo 18; s. 11914
Hlavní autori: Cowan, Simone, Hatziioannou, Theodora, Cunningham, Tshaka, Muesing, Mark A, Gottlinger, Heinrich G, Bieniasz, Paul D
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 03.09.2002
Predmet:
ISSN:0027-8424
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Many nonhuman primate cells are unable to support the replication of HIV-1, whereas others are nonpermissive for infection by simian immunodeficiency virus from macaques (SIVmac). Here, we show that restricted HIV-1 and SIVmac infection of primate cell lines shares some salient features with Fv1 and Ref1-mediated restriction of murine retrovirus infection. In particular, the nonpermissive phenotype is most evident at low multiplicities of infection, results in reduced accumulation of reverse transcription products, and is dominant in heterokaryons generated by fusion of permissive and nonpermissive target cells. Moreover, in nonpermissive primate cells, HIV-1 and SIVmac infection is cooperative, and enveloped HIV-1 virus-like particles, minimally containing Gag and protease, abrogate restriction. In African green monkey cells, HIV-1 virus-like particles ablate restrictions to HIV-1 and SIVmac, suggesting that both are restricted by the same factor. Finally, a virus that contains an HIV-1 capsid-p2 domain in an SIVmac background exhibits a tropism for primate cells that is HIV-1-like rather than SIVmac-like. These data indicate the existence of one or more saturable inhibitors that are polymorphic in primates and prevent HIV and SIV infection by targeting the capsid of the incoming lentivirus particle.
AbstractList Many nonhuman primate cells are unable to support the replication of HIV-1, whereas others are nonpermissive for infection by simian immunodeficiency virus from macaques (SIVmac). Here, we show that restricted HIV-1 and SIVmac infection of primate cell lines shares some salient features with Fv1 and Ref1-mediated restriction of murine retrovirus infection. In particular, the nonpermissive phenotype is most evident at low multiplicities of infection, results in reduced accumulation of reverse transcription products, and is dominant in heterokaryons generated by fusion of permissive and nonpermissive target cells. Moreover, in nonpermissive primate cells, HIV-1 and SIVmac infection is cooperative, and enveloped HIV-1 virus-like particles, minimally containing Gag and protease, abrogate restriction. In African green monkey cells, HIV-1 virus-like particles ablate restrictions to HIV-1 and SIVmac, suggesting that both are restricted by the same factor. Finally, a virus that contains an HIV-1 capsid-p2 domain in an SIVmac background exhibits a tropism for primate cells that is HIV-1-like rather than SIVmac-like. These data indicate the existence of one or more saturable inhibitors that are polymorphic in primates and prevent HIV and SIV infection by targeting the capsid of the incoming lentivirus particle.Many nonhuman primate cells are unable to support the replication of HIV-1, whereas others are nonpermissive for infection by simian immunodeficiency virus from macaques (SIVmac). Here, we show that restricted HIV-1 and SIVmac infection of primate cell lines shares some salient features with Fv1 and Ref1-mediated restriction of murine retrovirus infection. In particular, the nonpermissive phenotype is most evident at low multiplicities of infection, results in reduced accumulation of reverse transcription products, and is dominant in heterokaryons generated by fusion of permissive and nonpermissive target cells. Moreover, in nonpermissive primate cells, HIV-1 and SIVmac infection is cooperative, and enveloped HIV-1 virus-like particles, minimally containing Gag and protease, abrogate restriction. In African green monkey cells, HIV-1 virus-like particles ablate restrictions to HIV-1 and SIVmac, suggesting that both are restricted by the same factor. Finally, a virus that contains an HIV-1 capsid-p2 domain in an SIVmac background exhibits a tropism for primate cells that is HIV-1-like rather than SIVmac-like. These data indicate the existence of one or more saturable inhibitors that are polymorphic in primates and prevent HIV and SIV infection by targeting the capsid of the incoming lentivirus particle.
Many nonhuman primate cells are unable to support the replication of HIV-1, whereas others are nonpermissive for infection by simian immunodeficiency virus from macaques (SIVmac). Here, we show that restricted HIV-1 and SIVmac infection of primate cell lines shares some salient features with Fv1 and Ref1-mediated restriction of murine retrovirus infection. In particular, the nonpermissive phenotype is most evident at low multiplicities of infection, results in reduced accumulation of reverse transcription products, and is dominant in heterokaryons generated by fusion of permissive and nonpermissive target cells. Moreover, in nonpermissive primate cells, HIV-1 and SIVmac infection is cooperative, and enveloped HIV-1 virus-like particles, minimally containing Gag and protease, abrogate restriction. In African green monkey cells, HIV-1 virus-like particles ablate restrictions to HIV-1 and SIVmac, suggesting that both are restricted by the same factor. Finally, a virus that contains an HIV-1 capsid-p2 domain in an SIVmac background exhibits a tropism for primate cells that is HIV-1-like rather than SIVmac-like. These data indicate the existence of one or more saturable inhibitors that are polymorphic in primates and prevent HIV and SIV infection by targeting the capsid of the incoming lentivirus particle.
Author Muesing, Mark A
Gottlinger, Heinrich G
Hatziioannou, Theodora
Cunningham, Tshaka
Bieniasz, Paul D
Cowan, Simone
Author_xml – sequence: 1
  givenname: Simone
  surname: Cowan
  fullname: Cowan, Simone
  organization: Aaron Diamond AIDS Research Center, Rockefeller University, 455 First Avenue, New York, NY 10016, USA
– sequence: 2
  givenname: Theodora
  surname: Hatziioannou
  fullname: Hatziioannou, Theodora
– sequence: 3
  givenname: Tshaka
  surname: Cunningham
  fullname: Cunningham, Tshaka
– sequence: 4
  givenname: Mark A
  surname: Muesing
  fullname: Muesing, Mark A
– sequence: 5
  givenname: Heinrich G
  surname: Gottlinger
  fullname: Gottlinger, Heinrich G
– sequence: 6
  givenname: Paul D
  surname: Bieniasz
  fullname: Bieniasz, Paul D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12154227$$D View this record in MEDLINE/PubMed
BookMark eNo1kD1PwzAYhD0U0Q9YGZEntoD91onjEVUUkCqxwBzZjq2-kDjFdor674lEme6GR6e7W5JZGIIj5Iaze87k-uEQdLrnFYBSQqkZWTAGsqgFiDlZpvTJGFNlzS7JnAMvBYBcELtxXTd2OlIMezSYh5joD-Y93R550eGXo9pmPGI-0ehSjmgz3Y-9DlSHlibscbLY92MYWufRogv2RI8Yx0RzHA6Y-ity4XWX3PVZV-Rj-_S-eSl2b8-vm8ddYUvguRC-Fto57kFJD5ZJb8CAgrK1bcW5VEzqsnS6AmdaI7hZAytbJVsjvfdVBSty95d7iMP3OJVtekx22qeDG8bUyImvRQkTeHsGR9O7tjlE7HU8Nf-3wC_hNmcN
CitedBy_id crossref_primary_10_1128_JVI_79_22_14446_14450_2005
crossref_primary_10_1128_JVI_80_1_342_352_2006
crossref_primary_10_1186_s12977_015_0208_y
crossref_primary_10_1016_j_virol_2005_06_005
crossref_primary_10_1089_0889222041524652
crossref_primary_10_1007_s11904_006_0004_3
crossref_primary_10_1074_jbc_M117_793661
crossref_primary_10_1128_JVI_79_10_6111_6121_2005
crossref_primary_10_1016_j_virol_2004_08_006
crossref_primary_10_1128_JVI_02254_16
crossref_primary_10_1128_JVI_80_5_2463_2471_2006
crossref_primary_10_1016_j_mib_2006_06_011
crossref_primary_10_2217_17460794_1_1_71
crossref_primary_10_1074_jbc_M109_040618
crossref_primary_10_1097_00002030_200216004_00003
crossref_primary_10_1128_JVI_01134_14
crossref_primary_10_1111_j_1348_0421_2008_00040_x
crossref_primary_10_1016_j_ymthe_2005_07_291
crossref_primary_10_1128_JVI_79_18_11580_11587_2005
crossref_primary_10_1128_JVI_01880_07
crossref_primary_10_1128_JVI_78_21_11816_11822_2004
crossref_primary_10_1128_JVI_78_18_9592_9598_2004
crossref_primary_10_1089_hum_2015_059
crossref_primary_10_1016_j_virol_2006_05_035
crossref_primary_10_1128_JVI_00713_13
crossref_primary_10_1186_1742_4690_2_25
crossref_primary_10_1128_JVI_79_3_1470_1479_2005
crossref_primary_10_1073_pnas_0509996103
crossref_primary_10_1089_hum_2008_186
crossref_primary_10_1016_j_virol_2010_09_019
crossref_primary_10_1111_j_1600_0684_2006_00172_x
crossref_primary_10_1128_JVI_00410_08
crossref_primary_10_1038_ni1125
crossref_primary_10_1128_JVI_00984_20
crossref_primary_10_1007_s00726_009_0393_x
crossref_primary_10_1007_s10495_009_0408_9
crossref_primary_10_1128_JVI_79_5_3139_3145_2005
crossref_primary_10_1186_1742_4690_6_70
crossref_primary_10_1128_JVI_78_4_2006_2016_2004
crossref_primary_10_1146_annurev_genet_42_110807_091704
crossref_primary_10_1038_s41579_019_0225_2
crossref_primary_10_1016_j_virol_2007_02_002
crossref_primary_10_1186_1472_6807_4_1
crossref_primary_10_1371_journal_ppat_1002019
crossref_primary_10_1083_jcb_200706154
crossref_primary_10_1007_s12026_010_8164_z
crossref_primary_10_1016_j_virusres_2013_01_013
crossref_primary_10_1371_journal_ppat_1000074
crossref_primary_10_1016_j_virol_2014_02_004
crossref_primary_10_1038_nm0703_887
crossref_primary_10_1089_hum_2005_16_ft_113
crossref_primary_10_1016_j_cub_2004_12_042
crossref_primary_10_1002_jgm_1554
crossref_primary_10_1146_annurev_genet_112414_054823
crossref_primary_10_1128_JVI_79_2_869_875_2005
crossref_primary_10_1186_1742_4690_4_68
crossref_primary_10_1016_j_tim_2008_08_013
crossref_primary_10_3390_biology1020134
crossref_primary_10_1128_jvi_00308_24
crossref_primary_10_1089_cell_2012_0041
crossref_primary_10_1128_JVI_78_2_1006_1011_2004
crossref_primary_10_1186_1742_4690_9_112
crossref_primary_10_1371_journal_ppat_1003214
crossref_primary_10_1038_sj_mt_6300244
crossref_primary_10_1128_JVI_80_4_2051_2054_2006
crossref_primary_10_1128_JVI_80_8_4061_4067_2006
crossref_primary_10_1128_JVI_01519_06
crossref_primary_10_1016_j_virol_2006_10_035
crossref_primary_10_1186_s12977_015_0137_9
crossref_primary_10_1073_pnas_1111573109
crossref_primary_10_1099_jgv_0_001790
crossref_primary_10_1128_JVI_00432_08
crossref_primary_10_1128_JVI_02663_07
crossref_primary_10_1073_pnas_0337541100
crossref_primary_10_1073_pnas_0404640101
crossref_primary_10_1016_j_vetimm_2011_06_014
crossref_primary_10_1002_rmv_417
crossref_primary_10_1128_JVI_00821_17
crossref_primary_10_1128_JVI_78_11_6005_6012_2004
crossref_primary_10_1371_journal_ppat_1005050
crossref_primary_10_1128_JVI_77_5_3167_3180_2003
crossref_primary_10_1128_JVI_02727_06
crossref_primary_10_1016_j_imlet_2004_11_026
crossref_primary_10_2217_17460794_2_1_65
crossref_primary_10_1186_s12977_016_0253_1
crossref_primary_10_1099_vir_0_058180_0
crossref_primary_10_1371_journal_ppat_1005727
crossref_primary_10_1371_journal_ppat_1001255
crossref_primary_10_1073_pnas_0709258105
crossref_primary_10_1016_j_virol_2006_09_048
crossref_primary_10_1128_JVI_77_17_9295_9304_2003
crossref_primary_10_1128_JVI_78_22_12537_12547_2004
crossref_primary_10_1038_nm910
crossref_primary_10_1128_JVI_78_10_5423_5437_2004
crossref_primary_10_7554_eLife_54311
crossref_primary_10_1128_AAC_05722_11
crossref_primary_10_1290_1543_706X_2004_40_57_IAOTCF_2_0_CO_2
crossref_primary_10_1016_j_tim_2005_08_004
crossref_primary_10_1016_j_virol_2006_04_021
crossref_primary_10_1182_blood_2008_04_151761
crossref_primary_10_1038_sj_gt_3302591
crossref_primary_10_1016_j_molcel_2004_12_001
crossref_primary_10_1371_journal_ppat_1003667
crossref_primary_10_1186_1742_4690_6_21
crossref_primary_10_1016_S0929_6646_11_60053_3
crossref_primary_10_1128_AAC_00775_09
crossref_primary_10_1186_s12977_017_0358_1
crossref_primary_10_1128_JVI_01052_06
crossref_primary_10_1038_nm1562
crossref_primary_10_1016_j_bbrc_2008_02_025
crossref_primary_10_1182_blood_2003_07_2414
crossref_primary_10_1073_pnas_0510483103
crossref_primary_10_1128_JVI_00620_07
crossref_primary_10_1038_gt_2008_50
crossref_primary_10_1073_pnas_192449399
crossref_primary_10_1074_jbc_M111_248021
crossref_primary_10_1128_JVI_06607_11
crossref_primary_10_1128_JVI_77_24_13403_13406_2003
crossref_primary_10_1038_nature02777
crossref_primary_10_1073_pnas_0404066101
crossref_primary_10_1097_01_COH_0000221591_11294_c1
crossref_primary_10_1128_JVI_02548_12
crossref_primary_10_1073_pnas_0403364101
crossref_primary_10_1186_1742_4690_9_30
crossref_primary_10_1038_mt_sj_6300091
crossref_primary_10_1053_j_seminhematol_2004_07_004
crossref_primary_10_1128_JVI_00283_06
crossref_primary_10_1002_rmv_576
crossref_primary_10_1128_JVI_78_12_6209_6221_2004
crossref_primary_10_1073_pnas_0600771103
crossref_primary_10_1016_S1773_035X_10_70558_X
crossref_primary_10_1111_j_1600_0854_2006_00449_x
crossref_primary_10_1073_pnas_0402876101
crossref_primary_10_1155_2012_426840
crossref_primary_10_1074_jbc_M606066200
crossref_primary_10_1016_j_antiviral_2009_09_009
crossref_primary_10_1128_JVI_79_24_15175_15188_2005
crossref_primary_10_1182_blood_2004_01_0045
crossref_primary_10_1097_QAD_0b013e3282effa87
crossref_primary_10_1128_JVI_01022_12
crossref_primary_10_1016_j_virol_2006_03_013
crossref_primary_10_1128_JVI_79_10_6560_6564_2005
crossref_primary_10_1128_JVI_79_24_15567_15572_2005
crossref_primary_10_1159_000346963
crossref_primary_10_1016_j_virol_2007_04_005
crossref_primary_10_1517_14728222_12_2_131
crossref_primary_10_1128_JVI_01228_16
crossref_primary_10_1089_hum_2005_16_1125
crossref_primary_10_1128_JVI_00854_10
crossref_primary_10_1074_jbc_M502145200
crossref_primary_10_1128_JVI_01338_20
crossref_primary_10_1016_j_virol_2006_03_023
crossref_primary_10_1128_JVI_78_21_11739_11750_2004
crossref_primary_10_1073_pnas_0402361101
crossref_primary_10_1073_pnas_0402474101
crossref_primary_10_3390_v6010243
crossref_primary_10_1128_JVI_80_6_2855_2862_2006
crossref_primary_10_1016_j_virol_2004_04_038
crossref_primary_10_1111_j_1600_0854_2012_01381_x
crossref_primary_10_1038_nature02343
crossref_primary_10_1371_journal_pone_0002796
crossref_primary_10_1128_JVI_01118_19
crossref_primary_10_3390_ijms20122984
crossref_primary_10_1089_jir_2009_0077
crossref_primary_10_1038_sj_mt_6300091
crossref_primary_10_1016_j_vaccine_2009_08_060
crossref_primary_10_1073_pnas_1203536109
crossref_primary_10_1186_1742_4690_10_25
crossref_primary_10_1091_mbc_e06_12_1075
crossref_primary_10_1182_blood_2010_12_327106
crossref_primary_10_1016_j_virol_2008_05_008
crossref_primary_10_1128_JVI_00269_08
crossref_primary_10_1128_JVI_02318_06
crossref_primary_10_1128_JVI_02427_05
crossref_primary_10_1038_nrmicro1248
crossref_primary_10_1073_pnas_0505659102
crossref_primary_10_1182_blood_2007_09_115022
crossref_primary_10_1038_nrmicro772
crossref_primary_10_1128_JVI_01468_07
crossref_primary_10_1038_gt_2010_40
crossref_primary_10_1016_S0168_9525_03_00172_0
crossref_primary_10_1128_JVI_00341_11
crossref_primary_10_1186_1742_4690_1_9
crossref_primary_10_1186_1742_4690_10_37
crossref_primary_10_1371_journal_pone_0084022
crossref_primary_10_1128_JVI_77_1_726_731_2003
crossref_primary_10_1128_JVI_79_14_8969_8978_2005
crossref_primary_10_1002_jcp_21914
crossref_primary_10_1038_nm0903_1112
crossref_primary_10_1128_JVI_00500_10
crossref_primary_10_1186_1742_4690_2_40
crossref_primary_10_3390_v3020132
crossref_primary_10_1128_JVI_03598_14
crossref_primary_10_1128_JVI_02462_07
crossref_primary_10_1016_j_virol_2007_08_032
crossref_primary_10_1038_sj_gt_3302852
crossref_primary_10_1128_JVI_02714_06
crossref_primary_10_1038_srep37489
crossref_primary_10_1128_JVI_00688_06
crossref_primary_10_1097_00002030_200307040_00002
crossref_primary_10_1038_427791a
crossref_primary_10_3389_fmicb_2021_652486
crossref_primary_10_1016_S0966_842X_03_00123_9
crossref_primary_10_4103_ijmm_IJMM_20_109
crossref_primary_10_1517_14712598_6_11_1135
crossref_primary_10_1128_JVI_00270_06
crossref_primary_10_1371_journal_pone_0114299
crossref_primary_10_1128_JVI_06035_11
crossref_primary_10_1128_JVI_00516_06
crossref_primary_10_1128_JVI_79_1_176_183_2005
crossref_primary_10_1128_JVI_79_7_3930_3937_2005
crossref_primary_10_1146_annurev_genet_38_072902_094136
crossref_primary_10_1186_1742_4690_7_72
crossref_primary_10_3390_v16101618
crossref_primary_10_1128_JVI_02665_08
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1073/pnas.162299499
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Sciences (General)
ExternalDocumentID 12154227
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01AI50111
– fundername: NIAID NIH HHS
  grantid: R01 AI047054
– fundername: NIAID NIH HHS
  grantid: R01 AI050111
– fundername: NIAID NIH HHS
  grantid: R01AI47054
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29P
2AX
2FS
2WC
3O-
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
AAYJJ
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACHIC
ACIWK
ACNCT
ACPRK
ADULT
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
AS~
BKOMP
CGR
CS3
CUY
CVF
D0L
DCCCD
DIK
DOOOF
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
HGD
HH5
HQ3
HTVGU
HYE
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KQ8
L7B
LU7
MVM
N9A
NEJ
NPM
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHF
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
VOH
VQA
VXZ
W8F
WH7
WHG
WOQ
WOW
X7M
XSW
Y6R
YBH
YIF
YIN
YKV
YSK
ZCA
ZCG
~02
~KM
7X8
ADQXQ
ADXHL
ID FETCH-LOGICAL-c521t-4f84aee1f297f2c07fb2b2925dcd6117907a55ea62ebdb41b3205d97db7fff662
IEDL.DBID 7X8
ISICitedReferencesCount 248
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000177843100068&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0027-8424
IngestDate Sun Aug 24 04:01:17 EDT 2025
Wed Feb 19 02:02:46 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c521t-4f84aee1f297f2c07fb2b2925dcd6117907a55ea62ebdb41b3205d97db7fff662
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://doi.org/10.1073/pnas.162299499
PMID 12154227
PQID 72058452
PQPubID 23479
ParticipantIDs proquest_miscellaneous_72058452
pubmed_primary_12154227
PublicationCentury 2000
PublicationDate 2002-09-03
PublicationDateYYYYMMDD 2002-09-03
PublicationDate_xml – month: 09
  year: 2002
  text: 2002-09-03
  day: 03
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 2002
References 12195025 - Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11549-51. doi: 10.1073/pnas.192449399
References_xml – reference: 12195025 - Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11549-51. doi: 10.1073/pnas.192449399
SSID ssj0009580
Score 2.219803
Snippet Many nonhuman primate cells are unable to support the replication of HIV-1, whereas others are nonpermissive for infection by simian immunodeficiency virus...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 11914
SubjectTerms Animals
Antiviral Agents
Cell Line
HIV-1 - physiology
Humans
Proteins - physiology
Simian Immunodeficiency Virus - physiology
Transcription, Genetic
Tropism
Virus Replication
Title Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
URI https://www.ncbi.nlm.nih.gov/pubmed/12154227
https://www.proquest.com/docview/72058452
Volume 99
WOSCitedRecordID wos000177843100068&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT-MwELUK7IELH7sLlK_1gQN7MDRjJ04kJIQQFRcqDrtSb5U_hUVJSlP6-_GkicQJDlxyiBTJsZ_HY4_fe4SciYxraaxi4G3KBIBjyglgwsbths3iS6kbswk5GuXjcfHYI1cdFwavVXYxsQnUtjJ4Rn4pYRDXyhSuZ68MPaOwttoaaKyRDR4TGcS0HOcfJHfzFQEFYhwWIDrJRskvZ6WqL5IMYiwWxSfJZbPIDLe_17wdstUml_RmhYZd0nPlT7LbTt-anrca039_EXPrplO8gUpD-RR0QM8dimeydLhM2DQ8O4qMBzSWoOjeEaPlgjZ-flSVltbhJcKKBiSXVNahCgVSOOkyzN9quphXs1C__Cb_h3f_bu9Z67fADNoaMOFzoZxLPBTSgxlIr0FDAak1NkPpuIFUaepUBk5bLRLN40_bQlotvfdZBntkvaxKd0BoyrUCy0WmwQgBAx0zDaVym3KjE56oPvnTdeMk4hmLFKp01Vs96TqyT_ZXIzGZrWQ3JqiDEcEkD7_89ohsNqYtWPfhx2TDx5nsTsgPs1yEen7awCQ-R48P7zc0ykc
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cellular+inhibitors+with+Fv1-like+activity+restrict+human+and+simian+immunodeficiency+virus+tropism&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Cowan%2C+Simone&rft.au=Hatziioannou%2C+Theodora&rft.au=Cunningham%2C+Tshaka&rft.au=Muesing%2C+Mark+A&rft.date=2002-09-03&rft.issn=0027-8424&rft.volume=99&rft.issue=18&rft.spage=11914&rft_id=info:doi/10.1073%2Fpnas.162299499&rft_id=info%3Apmid%2F12154227&rft_id=info%3Apmid%2F12154227&rft.externalDocID=12154227
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8424&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8424&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8424&client=summon